Christian Elze
Fortuna: 19 275 $ al 31/08/2026
Fortuna: 19 275 $ al 31/08/2026
Christian Elze is the founder of Catenion GmbH, founded in 2003.
Mr. Elze currently holds the position of Director at Protalix Biotherapeutics, Inc., starting in 2025.
Mr. Elze completed an MBA at The Trustees of Columbia University in The City of New York and an undergraduate degree at the London School of Economics & Political Science.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 03/09/2026 | 7.500 ( 0,01 % ) | 19 275 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Director/Miembro de la Junta | 26/06/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
Catenion GmbH
Catenion GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Catenion GmbH
Catenion GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.